June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Correction of diabetic retinopathy by mitochondrial transfer
Author Affiliations & Notes
  • Denis A Proshlyakov
    Physiology, Michigan State University, East Lansing, Michigan, United States
  • Sandra S Hammer
    Physiology, Michigan State University, East Lansing, Michigan, United States
  • Sergio Li Calzi
    Department of Ophthalmology and Visual Science, University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Tim Florian Dorweiler
    Physiology, Michigan State University, East Lansing, Michigan, United States
  • Cristiano P. Vieira
    Department of Ophthalmology and Visual Science, University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Kiera Fisher
    Physiology, Michigan State University, East Lansing, Michigan, United States
  • Shari Atilano
    Ophthalmology Clinical, University of California Irvine, Irvine, California, United States
  • M.Cristina Kenney
    Ophthalmology Clinical, University of California Irvine, Irvine, California, United States
  • Julia V Busik
    Physiology, Michigan State University, East Lansing, Michigan, United States
  • Maria B Grant
    Department of Ophthalmology and Visual Science, University of Alabama at Birmingham, Birmingham, Alabama, United States
  • Footnotes
    Commercial Relationships   Denis Proshlyakov None; Sandra Hammer None; Sergio Li Calzi None; Tim Dorweiler None; Cristiano Vieira None; Kiera Fisher None; Shari Atilano None; M.Cristina Kenney None; Julia Busik Ceramedix, Code C (Consultant/Contractor); Maria Grant None
  • Footnotes
    Support  NH Grant EY028049
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 791 – F0350. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Denis A Proshlyakov, Sandra S Hammer, Sergio Li Calzi, Tim Florian Dorweiler, Cristiano P. Vieira, Kiera Fisher, Shari Atilano, M.Cristina Kenney, Julia V Busik, Maria B Grant; Correction of diabetic retinopathy by mitochondrial transfer. Invest. Ophthalmol. Vis. Sci. 2022;63(7):791 – F0350.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mitochondrial (Mt) damage precedes histopathological abnormalities in diabetic retinopathy (DR). Recent studies show that Mt transfer can rescue cells from bioenergetic abnormalities and cell death. This study in DR cell culture and animal models examines whether i) Mt transfer can normalize bioenergetics of retinal cells and ii) if bone marrow derived mesenchymal stem cells (MSC) represent a source of Mt for transfer to damaged retinal endothelial cells (REC).

Methods : BREC, hMSC, and ARPE19 cells were cultured using established protocols. ARPE19 cells were depleted of mitochondria by culturing in media containing 50 ng/ml ethidium bromide and 50 µg/ml uridine for up to six passages. Mt were labeled using rLV-EF1-EGFP infection. Mt were isolated using differential centrifugation protocols. Mt haplogroups were analyzed at the sequence depth ID 30,000; range 1,000 to 100,000. Respiratory activity was assessed using a custom microfluidic respirometer. Retinal ischemia-reperfusion (I/R) mouse model was used to assess Mt transfer in vivo.

Results : The effect of Mt transfer on bioenergetics was assessed in Mt depleted Rhoo ARPE19 cells. ARPE19 cells have U5 mitochondrial haplogroup with high respiratory activity, however adherent Rhoo ARPE19 cells had no significant respiratory activity (0.2±0.08 pmol O2/sec/106 cells). Overnight incubation of adherent Rhoo ARPE19 cells with Mt isolated from control ARPE19 cells led to progressive increase in the respiratory activity over 10 days up to 3.4±0.7 pmol O2/sec/106 cells, which is equivalent to the activity of the wild type ARPE19 cells at day 10 (4.2±1.7 pmol O2/sec/106 cells). Moreover, normalization of respiratory activity due to Mt transfer improved viability and increased growth rate of Rhoo ARPE19 cells. We next determined if Mt transfer occurs between vascular progenitor cells and REC in DR cell culture and animal models. BREC treated with TNFα (10 ng/ml) for 24 hrs induced tunnelling nanotube (TNT) formation and Mt transfer by non-diabetic hMSC. No Mt transfer was observed in control BREC. 4 days following injection of MSC, TNT formation and Mt transfer was observed using IHC in I/R injured, but not in the uninjured mouse eye when injected with hMSC.

Conclusions : Exogenous Mt incorporate into cellular mitochondrial networks and normalize bioenergetics of damaged retinal cells. Mt transfer is a mechanism that provides paracrine support to damaged retinal vasculature.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×